Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Melanotan 2 at a Glance Melanotan 2 (alpha-MSH Analog) Type: Synthetic analog of alpha-MSH | Primary Target: MC1R (melanocortin 1 receptor) | Secondary Targets: MC3R, MC4R, MC5R | Primary Effect: Skin darkening (eumelanin production) | Secondary Effects: Sexual arousal, appetite suppression | Route: Subcutaneous injection | FDA Status: Not approved | Related: PT-141 (bremelanotide), derived from MT-2 research MT-2 was originally developed at the University of Arizona in the 1990s as a potential preventive treatment for skin cancer
Semaglutide has proven CV benefit
Three more peptides were considered on Friday, and two of them, Semax and Epitalon, were also approved
Starting May 29, 2026, eligible patients without public or private drug coverage can access additional savings on the brand-name medicine
This product has multiple variants
US$ 29.38
US$ 22.51
US$ 25.79
US$ 24.31
US$ 29.77
US$ 25.09
US$ 27.08
US$ 26.75
US$ 20.45
